News

ePatientFinder and Rep Network have announced a partnership that aims to provide clinical trial access to patients nationally.

BioPlan has released its updated textbook, A Quick Guide to Clinical Trials, 2nd Edition.

Updated employee announcements, business news, awards and recognition in the industry today.

Medidata announces the acquisition of eClinical technology company, Mytrus Inc. Medidata will add Mytrus’ eConsent solution, Enroll, into the Medidata Clinical Cloud.

Why taking a right-sized approach to real-world studies will help keep sites and patients around for the duration.

Examining early learnings from approaches used to comply with EMA’s requirement to publish anonymized versions of clinical study reports and other submission documents, including how privacy protection was balanced against data utility.

In today’s value-driven healthcare system, real-world studies are increasingly becoming mandated by regulators as a condition of approval for new medicines.

YPrime has announced the release of its of its data-driven electronic clinical outcome assessment (eCOA) technology platform.

An international panel of industry experts has concluded that randomized, controlled clinical trials provide the fastest and most reliable way to identify the risks and benefits of treatment candidates for infectious disease outbreaks.

MedNet Solutions announced that its eClinical solution, iMedNet, now leverages Amazon Web Services, as well as ClearDATA's security and infrastructure services.

Jeremy Sohn, VP, Global Head of Digital Business Development & Licensing at Novartis, delves into how biopharma is incorporating digital strategy into the execution of patient centric studies.

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.

TrialScope, a company focused on clinical study transparency, has launched ATLAS Global Compliance.

PMG Research and Devana Solutions, LLC have announced a long-term subscription agreement.

The pharma industry agrees that the importance of entering data into an EDC as soon as possible following a subject is paramount. Slow site data entry can impact the credibility and usefulness of centralized monitoring data analytic reports.

Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform.

The pharma industry agrees that the importance of entering data into an EDC as soon as possible following a subject is paramount. Slow site data entry can impact the credibility and usefulness of centralized monitoring data analytic reports.

Chubb has expanded its global clinical trial liability insurance coverage for research organizations that face risks associated with managing clinical trials.